Aggressive pituitary tumours: the role of temozolomide and the assessment of MGMT status
Background Aggressive pituitary tumours are associated with substantial morbidity and mortality. Treatment options are often limited, and chemotherapy has been reserved as salvage therapy although historically results have often been disappointing. However, temozolomide, an oral alkylating agent, ha...
| Autores principales: | , , |
|---|---|
| Formato: | Journal article |
| Lenguaje: | English |
| Publicado: |
2011
|
Search Result 1
Aggressive pituitary tumours: the role of temozolomide and the assessment of MGMT status.
Publicado 2011
Journal article